{"id":"https://openalex.org/W7225657296","doi":"https://doi.org/10.1080/1750743x.2026.2758055","title":"Cost-effectiveness analysis of tarlatamab as second-line therapy for small-cell lung cancer after platinum-based chemotherapy","display_name":"Cost-effectiveness analysis of tarlatamab as second-line therapy for small-cell lung cancer after platinum-based chemotherapy","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225657296","doi":"https://doi.org/10.1080/1750743x.2026.2758055","pmid":"https://pubmed.ncbi.nlm.nih.gov/43000997"},"language":"en","primary_location":{"id":"doi:10.1080/1750743x.2026.2758055","doi":"https://doi.org/10.1080/1750743x.2026.2758055","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1750743x.2026.2758055","pdf_url":null,"source":{"id":"https://openalex.org/S71887004","display_name":"Immunotherapy","issn_l":"1750-743X","issn":["1750-743X","1750-7448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161338573","display_name":"Zhengxiong Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177388780","display_name":"Xuzhou Medical College","ror":"https://ror.org/04fe7hy80","country_code":"CN","type":"education","lineage":["https://openalex.org/I177388780"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhengxiong Li","raw_affiliation_strings":["Xuzhou Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xuzhou Medical University","institution_ids":["https://openalex.org/I177388780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161352610","display_name":"Jiaming Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114539943","display_name":"Zhejiang Chinese Medical University","ror":"https://ror.org/04epb4p87","country_code":"CN","type":"education","lineage":["https://openalex.org/I114539943"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiaming Zhu","raw_affiliation_strings":["Zhejiang Chinese Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Chinese Medical University","institution_ids":["https://openalex.org/I114539943"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5143515987","display_name":"Kai Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177388780","display_name":"Xuzhou Medical College","ror":"https://ror.org/04fe7hy80","country_code":"CN","type":"education","lineage":["https://openalex.org/I177388780"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Kai Ma","raw_affiliation_strings":["Xuzhou Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xuzhou Medical University","institution_ids":["https://openalex.org/I177388780"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5143515987"],"corresponding_institution_ids":["https://openalex.org/I177388780"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tarlatamab","display_name":"tarlatamab","score":1.0},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.875},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9679999947547913},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.5080000162124634},{"id":"https://openalex.org/keywords/relapsed-small-cell-lung-cancer","display_name":"relapsed small cell lung cancer","score":0.6690000295639038},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.9079999923706055},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8970000147819519},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.6069999933242798},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5099999904632568},{"id":"https://openalex.org/keywords/payer-perspective","display_name":"payer perspective","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8385000228881836},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7304999828338623},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6940000057220459},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6743999719619751},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6051999926567078},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.5873000025749207},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4862000048160553},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.47429999709129333},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.37560001015663147},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.36149999499320984},{"id":"https://openalex.org/C21200559","wikidata":"https://www.wikidata.org/wiki/Q7451068","display_name":"Sensitivity (control systems)","level":2,"score":0.35989999771118164},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3336000144481659},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3215000033378601},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.2921000123023987},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.27390000224113464},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.26190000772476196},{"id":"https://openalex.org/C49937458","wikidata":"https://www.wikidata.org/wiki/Q2599292","display_name":"Probabilistic logic","level":2,"score":0.2565000057220459},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.25609999895095825}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/1750743x.2026.2758055","doi":"https://doi.org/10.1080/1750743x.2026.2758055","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1750743x.2026.2758055","pdf_url":null,"source":{"id":"https://openalex.org/S71887004","display_name":"Immunotherapy","issn_l":"1750-743X","issn":["1750-743X","1750-7448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"journal-article"},{"id":"pmid:43000997","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43000997","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1982967337","https://openalex.org/W1993795505","https://openalex.org/W2015998714","https://openalex.org/W2017628547","https://openalex.org/W2128473443","https://openalex.org/W2128611498","https://openalex.org/W2296800272","https://openalex.org/W2519603001","https://openalex.org/W2906066359","https://openalex.org/W2913732573","https://openalex.org/W3020969154","https://openalex.org/W3080927742","https://openalex.org/W3130692824","https://openalex.org/W3139382474","https://openalex.org/W4200232423","https://openalex.org/W4200584507","https://openalex.org/W4206608028","https://openalex.org/W4210943873","https://openalex.org/W4313388450","https://openalex.org/W4319656591","https://openalex.org/W4321997033","https://openalex.org/W4366235587","https://openalex.org/W4376644329","https://openalex.org/W4380151508","https://openalex.org/W4387517250","https://openalex.org/W4389209433","https://openalex.org/W4393935425","https://openalex.org/W4400785807","https://openalex.org/W4403006206","https://openalex.org/W4403130179","https://openalex.org/W4403317464","https://openalex.org/W4405917489","https://openalex.org/W4410961676","https://openalex.org/W4415817168","https://openalex.org/W4417481696","https://openalex.org/W7119533381","https://openalex.org/W7161788543","https://openalex.org/W7166010649"],"related_works":["https://openalex.org/W7155504587","https://openalex.org/W7155533194","https://openalex.org/W7161788543","https://openalex.org/W4413376027","https://openalex.org/W4410961676","https://openalex.org/W7111693956","https://openalex.org/W4411913398","https://openalex.org/W7162675253","https://openalex.org/W4411025712","https://openalex.org/W7213627913"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,124],"DeLLphi\u2011304":[2,74],"trial":[3],"demonstrated":[4],"that":[5,147],"tarlatamab":[6,33,107,133,148,169,200],"provides":[7],"superior":[8],"efficacy":[9,69],"compared":[10],"with":[11,15,105,110],"chemotherapy":[12,188],"in":[13],"patients":[14],"relapsed":[16],"small-cell":[17],"lung":[18],"cancer":[19],"(SCLC)":[20],"after":[21,186],"first\u2011line":[22],"platinum\u2011based":[23,187],"chemotherapy.":[24],"Our":[25],"study":[26],"aimed":[27],"to":[28,54,129,170,177,201],"evaluate":[29],"the":[30,41,63,73,82,118,130,135,153],"cost\u2011effectiveness":[31,65],"of":[32,113,122,132,137,156,161],"as":[34,180],"a":[35,49,144,181],"second\u2011line":[36,182],"treatment":[37,183],"for":[38,84,168,184,199],"SCLC":[39,185],"from":[40,72,81],"US":[42],"healthcare":[43],"payer":[44],"perspective.":[45],"METHODS:":[46],"We":[47],"developed":[48],"three-state":[50],"partitioned":[51],"survival":[52],"model":[53,99,125],"estimate":[55],"costs,":[56],"life\u2011years":[57,60],"(LYs),":[58],"quality\u2011adjusted":[59],"(QALYs),":[61],"and":[62,77,90,95,101,134],"incremental":[64],"ratio":[66],"(ICER).":[67],"Clinical":[68],"was":[70,108,126],"obtained":[71],"trial.":[75],"Costs":[76],"utilities":[78],"were":[79],"derived":[80],"Centers":[83],"Medicare":[85],"&":[86],"Medicaid":[87],"Services":[88],"data":[89],"published":[91],"literature.":[92],"Sensitivity,":[93],"scenario,":[94],"subgroup":[96],"analyses":[97],"assessed":[98],"uncertainty":[100],"heterogeneity.":[102],"RESULTS:":[103],"Compared":[104],"chemotherapy,":[106],"associated":[109],"an":[111],"ICER":[112],"$1,145,233.86/QALY,":[114],"which":[115],"substantially":[116],"exceeded":[117],"willingness\u2011to\u2011pay":[119],"(WTP)":[120],"threshold":[121,155],"$150,000/QALY.":[123,157],"most":[127],"sensitive":[128],"cost":[131],"utility":[136],"progression-free":[138],"survival.":[139],"Probabilistic":[140],"sensitivity":[141],"analysis":[142],"indicated":[143],"0%":[145],"probability":[146],"would":[149,165],"be":[150,166,178,197],"cost-effective":[151],"at":[152,189],"WTP":[154],"A":[158],"price":[159,194],"reduction":[160],"more":[162],"than":[163],"82.34%":[164],"required":[167],"achieve":[171],"cost\u2011effectiveness.":[172],"CONCLUSIONS:":[173],"Tarlatamab":[174],"is":[175],"unlikely":[176],"cost\u2011effective":[179],"its":[190],"current":[191],"price.":[192],"Substantial":[193],"reductions":[195],"may":[196],"necessary":[198],"become":[202],"cost-effective.":[203]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}